HBI Deals+Insights / COVID-19
Profits at lab group Bejing Genomics Institute (BGI) are up 734% in the first half of the year after the company rapidly built 58 labs in 18 countries and sold 35m testing kits to 92% of the countries in the world for COVID-19. Yet the company is now caught up in the ever-escalating US-China trade war as two subsidiaries have been blacklisted by the States. HBI examines what this means for its global reach.